MiR-19a-3p targets the expression of IGFBP-3, which is tumor-suppressive in this cancer; thus miR-19a-3p increases the growth and invasiveness of ovarian cancer cells in vitro, and the growth of xenograft tumors in vivo [54]. Here, IGFBP3 is linked to neoplasm.